Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 5, 2008, Pages 597-603

  Foruny, José Ramón ^a   Boixeda, Daniel ^a   López Sanroman, Antonio ^a   Vázquez Sequeiros, Enrique ^a   Villafruela, Mónica ^a   Vázquez Romero, Manuel ^a   Rodríguez Gandía, Miguel ^a   De Argila, Carlos Martín ^a   Camarero, Cristina ^a   Milicua, José María ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Diagnosis; Penicillamine; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER; CUPRIPEN; PENICILLAMINE; TRANSFERASE; UNCLASSIFIED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABSENCE OF SIDE EFFECTS; ADOLESCENT; AGED; AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER LEVEL; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; URINARY EXCRETION; WILSON DISEASE;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; MALE; PENICILLAMINE;

EID: 42149189526     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701847044     Document Type: Article

References (26)

1. Gitlin JD. Wilson disease. Gastroenterology 2003;125:1868-77.
2. Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther 2004;19:157-65.
3. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-8.
4. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut 2000;46:415-9.
5. Ferenci P, Steindl-Munda P, Vogel W, Jessner W, Gschwantler M, Stauber R, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 2005;3:811-88.
6. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990;12:1234-9.
7. Sternlieb I. The outlook for the diagnosis of Wilson's disease. J Hepatol 1993;17:263-4.
8. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-42.
9. Dhawan A. Evaluation of the scoring system for the diagnosis of Wilson's disease in children. Liver Int 2005;25:680-1.
10. Tu JB, Blackwell RQ. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease. Metabolism 1967;16:507-13.
11. Kamoun P, Cadoudal M, Rabier D, Jerome H. Detection of Wilson's disease in sibs of a patient with Wilson's disease. Clin Chem 1986;32:392.
12. Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology 1992;15:609-15.
13. Gregorio GV, Mieli-Vergani G, Mowat AP. Urinary copper excretion after penicillamine in the diagnosis of Wilson's disease in children. J Hepatol 1993;19:489.
14. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003;37:1475-92.
15. Kingston HM, Jassie LB. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. Anal Chem 1986;58:2534-41.
16. Margarit E, Bach V, Gomez D, Bruguera M, Jara P, Queralt R, et al. Mutation analysis of Wilson disease in the Spanish population: identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet 2005;68:61-8.
17. Motulsky H. Intuitive biostatistics. New York: Oxford University Press; 1995. pp 272-6.
18. Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002;6:15-9.
19. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol 1997;27:358-62.
20. LaRusso NF, Summerskill WH, McCall JT. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology 1976;70:653-5.
21. Perman JA, Werlin SL, Grand RJ, Watkins JB. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr 1979;94:564-8.
22. Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981;21:169-78.
23. Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol 2001;34:165-71.
24. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
25. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-6.
26. Gong Y, Frederiksen SL, Gluud C. D-penicillamine for primary biliary cirrhosis. Cochrane Database Syst Rev 2004;18:CD004789.